# Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging

> **NCT05254132** · — · UNKNOWN · sponsor: **OncoRadiomics** · enrollment: 1000 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **PROCEDURE:** Liquid biopsy

## Key facts

- **NCT ID:** NCT05254132
- **Lead sponsor:** OncoRadiomics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05254132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05254132, "Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05254132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*